Related Experiment Video

Updated: Jan 28, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.4K

Dually Efficacious Medicine Against Fibrosis and Cancer

Daohong Chen1

  • 1Research Institute of Biological Medicine, Yiling Pharmaceutical; Beijing 102600, China. daohong@hotmail.com.

Medical Sciences (Basel, Switzerland)
|March 7, 2019
PubMed

Insights

Discover dual-efficacy medications targeting shared pathways in fibrosis and cancer. This research highlights molecular targets and approved drugs for treating both conditions simultaneously, advancing therapeutic strategies.

Area of Science:

  • Oncology
  • Pathology
  • Pharmacology

Background:

  • Severe diseases often require multi-targeted therapeutic combinations.
  • Distinct medical conditions can share patho-biological pathways.
  • Exploiting shared pathways can lead to dual-efficacy medications.

Purpose of the Study:

  • To present emerging molecular targets involved in both fibrotic and neoplastic disorders.
  • To review recently approved therapeutic agents for dual efficacy.
  • To streamline the overlapping mechanistic profile in pathogenesis for fibrosis and cancer.

Main Methods:

  • Identification of molecular targets common to fibrosis and cancer pathogenesis.
  • Review of therapeutic agents targeting these molecular pathways.
  • Analysis of drug efficacy in treating both conditions simultaneously.

Main Results:

  • Identified key molecular targets including kinase activities, cytokine cascades, and protein dynamics.
  • Corroborated the efficacy of approved agents in targeting these pathways for dual treatment.
  • Demonstrated an overlapping mechanistic profile in the pathogenesis of fibrosis and cancer.

Conclusions:

  • Shared molecular pathways offer opportunities for developing dual-efficacy medications.
  • Targeting these pathways can lead to simultaneous treatment of fibrosis and cancer.
  • This approach inspires innovation for tackling concomitant diseases effectively.
Keywords:
cancerdual efficacyfibrosis

More Related Videos

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Related Concept Videos

Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
219
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
864
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
516
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K